L-arginine can attenuate pulmonary hypertension (PH) by a mechanism that are not fully understood. This study investigated the molecule mechanism of L-arginine attenuating PH.
Introduction
There are still no efficient preventive and therapeutic methods available for pulmonary hypertension (PH) due to the fact that mechanisms, especially the molecular mechanisms of PH, are still not fully understood. Endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production decreases in PH. (10, 12, 14 (1, 17) We also showed in a PH animal model that eNOS expression is reduced in pulmonary arteries and peripheral lung, and that the association of eNOS with HSP90 is decreased in pulmonary artery and in hypertensive endothelial cells. (18) E-00107-2010/R2Ou et al, page 6
Although the use of various animal models has demonstrated L-arg-mediated increases in NO production and eNOS expression, and reduced O 2 •-generation, (5, 8, 40, 46) whether Larg affects the interaction of eNOS with HSP90 and the NO and O 2
•-balance in PH remains unknown. This study was designed to explore the impact of L-arg on such interaction and balance in a MCT-induced PH rat model.
Materials and Methods

Establishment of PH model
All animal experiments were approved by The First Affiliated Hospital, Sun Yat-sen Sprague-Dawley rats were injected intraperitoneally (i.p.) with a single dose (50 mg /kg) of MCT (Sigma-Aldrich, St. Louis, MO, USA) to induce PH as previously described. (39) Control rats received an equal volume of isotonic saline.
Study Groups
Six groups were studied. Control group (n=20) received a daily i.p injection of saline for 5
weeks. Animals in the L-arg group (n=20) received an i.p. dose of 500 mg/kg L-arg (Sigma-Aldrich) each day for 3 weeks (this dose has been shown to inhibit the development of PH (5, 15, 28) injection of L-arg (500 mg/kg) for 5 weeks. Body weight was recorded at the end of experimental period, except for control rats whose weight was measured at both 3 weeks and 5 weeks. Another 60 control, MCT and MCT/L-arg rats were used survival comparison. At the conclusion of the experiments, the subsequently described determinations were carried out.
Surgical preparation and measurement of pulmonary arterial pressure
Pulmonary artery pressure was measured using methods described previously. 
Effects of L-arg on pulmonary arterial vessel wall
Five micrometer-thick sections were made from paraffin-embedded lung blocks. H&E elastica staining was performed and the slides were examined by light microscopy in a blind fashion without the knowledge of treatment groups. In each section, 40-50 intraacinar arteries were counted. Each artery was first landmarked by its accompanying E-00107-2010/R2Ou et al, page 10 airway (i.e., terminal bronchiolus, respiratory bronchiolus, alveolar duct, or wall) and its smallest external diameter was measured. The mean arterial size was then calculated. In addition, each artery was identified as being of one of three structural types: muscular (with a complete medial coat of muscle), partially muscular (with an incomplete coat, only a crescent of muscle being present), or nonmuscular (no muscle apparent), as previously described.(37) The percent of fully muscularized arteries was determined. The wall thickness was measured at the two ends of the shortest external diameter and the average was taken. The percent wall thickness was calculated as {diameter (%) = (2 x wall thickness ÷ external diameter) x 100}.
Western analysis and immunoprecipitation
The expression of eNOS and HSP90, phosphorylation of eNOS at S1177 site, and HSP90 interaction with eNOS in lung were determined as described previously. (18, 19, 32) Briefly, frozen lung samples were pulverized and placed in a modified RIPA buffer. (18) The mixture was then homogenized, sonicated to break the cells, and the cell debris was Densities of the bands were quantified from the scanned images using NIH Image 1.63
software. Relative changes in eNOS phosphorylation (P-eNOS) at S1177 in lysates, and HSP90 association with eNOS in eNOS immunoprecipitates were determined as follows.
The band densities for P-eNOS at S1177 and HSP90 were divided by the band densities for the corresponding eNOS. The resulting ratios for P-eNOS/eNOS and HSP90/eNOS for the controls were used to calculate relative ratios for the six experimental groups, thereby making Control 1.0. To obtain relative changes for eNOS and HSP90 across treatments in densities, normalized to control, represent mean ± SEM as our previous described. (18, 33) 
Statistical Analysis
Differences among test groups were analyzed by ANOVA, using Bonferroni's Multiple
Comparison Test (Prism v4.0; GraphPad Software, San Diego, CA, USA) to determine levels of significance among groups, which was set at p<0.05. The survival rate was presented as Kaplan-Meier curve and compared by log-rank test.
See the online supplement for additional details on the methods for making these measurements.
Results
L-arg attenuates PH
As shown in Figure 1A , 
L-arg prolongs survival in MCT-induced PH rats
During the experiment period, 4 animals died in group MTC5 and 1 animal died in group MCT5/L-arg. Thus, to determine the effect of L-arg on the survival rate in MCT-induced PH, another set of experiments(60 rats, n=20 in each group) were performed. Some animals began to die 4 weeks after receiving an injection dose of MCT injection (95% survival at 4 weeks, 60% survival at 6 weeks). Interestingly, no animal deaths occurred in the L-arg treatment group 4 weeks post-MCT, and the survival rate at 6 weeks was 85%.
All rats of the control group survived for the entire experimental period ( Figure 1C , p<0.05, n= 20 each). MCT-treated animals displayed decreased body weight that was less than control animals ( Figure 1D , p<0.05, n=20-26). L-arg treatment prevented body weight loss in MCT-treated animals ( Figure 1D , p<0.05, n=25-26). L-arg alone had no effect on body weight ( Figure 1D , p>0.05, n=20).
L-arg restores NO generation in MCT-induced PH lung
NO concentration in the lung was significantly decreased at 3 weeks and 5 weeks post- Figure 3I .
Effects of L-arg on expression of eNOS, HSP90, and phosphorylation of eNOS at the
S1177 site in lung
The influence of L-arg on expression of eNOS and HSP90, and phosphorylation of eNOS at S1177 in MCT-induced PH lung was assessed. The representative blot of β-actin in Figure 4 showed that the amount of protein loading in each group is equal. The expression of eNOS and HSP90, and the phosphorylation of eNOS at S1177 site were markedly decreased in MCT-treated animals both at 3 weeks and 5 weeks compared to control lung.
L-arg could partially preserve eNOS expression and phosphorylation at S1177 both at 3 
Effects of L-arg on pulmonary vascular remodeling
As shown in Figure 6 , the wall thickness of fully muscularized distal pulmonary arteries increased with time post-MCT compared with control. L-arg partially inhibited MCTinduced vessel wall thickness of pulmonary arteries. L-arg itself had no effect on vessel wall thickness of pulmonary arteries in the control rats. to avoid this side effect induced by pentobarbital, all animals were anesthetized the same way in our study and the side effect should be limited. Another way to avoid the pentobarbital effect is using agent other than pentobarbital in the future study.
In summary, our findings indicate that PH has a deleterious effect on pulmonary 
